A study aimed to investigate the dose-response relationship of ciprofloxacin versus trimethoprim in the treatment of patients with severe renal failure. A total of 100 patients with severe renal failure were admitted to the department of ambulatory surgery between 1 and 12 months of age. The patients were treated with intravenous (IV) ciprofloxacin for 5 days or trimethoprim for 5 days. The dose of the medication was increased by 15% to 20% of the doses prescribed to each patient to prevent dose-limiting side effects. A positive response to the IV dose of ciprofloxacin was observed in a significant percentage of the patients. There was no statistical difference in the clearance of ciprofloxacin and trimethoprim between the two groups. Ciprofloxacin was effective in the treatment of severe renal failure, with a mean of 24.6 days in the group with IV ciprofloxacin. The mean difference in the clearance of ciprofloxacin and trimethoprim was 12.8 mL/min/1.73m2 and 13.1 mL/min/1.73m2, respectively. The overall survival rate in the treated patients was not significantly different from that in the control group. The IV ciprofloxacin dose-limiting side effects were observed in a significant percentage of the patients. Ciprofloxacin is effective in the treatment of severe renal failure.
ciprofloxacin, ciprofloxacin dosage, trimethoprim, creatinine, kidney
.
The patients were divided into two groups. Group A was given ciprofloxacin for 5 days or trimethoprim for 5 days, and group B was given ciprofloxacin for 5 days. The patients were randomly divided into two groups according to the response to the IV dose of ciprofloxacin. The treatment of each patient was started with IV ciprofloxacin therapy for 5 days or trimethoprim therapy for 5 days. The patients were followed up after 1 month. The patients who received ciprofloxacin for 5 days or trimethoprim for 5 days experienced a significantly higher incidence of severe adverse reactions in the IV group compared with the IV group. A higher incidence of severe adverse reactions was also observed in the trimethoprim group.
The treatment of Group A was completed for 1 month. The total dose of ciprofloxacin was 15 mg or 20 mg per day. The administration of ciprofloxacin was completed for 5 days or trimethoprim for 5 days. The patients in Group B received ciprofloxacin for 5 days or trimethoprim for 5 days. The total doses of ciprofloxacin were increased by 15% to 20% of the doses prescribed to each patient to prevent dose-limiting side effects.
The therapeutic response to ciprofloxacin in Group A was evaluated in a group of patients who were prescribed ciprofloxacin for 5 days or trimethoprim for 5 days. The mean difference in the dose of ciprofloxacin and trimethoprim was 1.1 mL/day, and there was no statistical difference in the clearance of ciprofloxacin and trimethoprim between the two groups.
The treatment of Group B was completed for 1 month. The patients in Group B experienced a significantly higher incidence of severe adverse reactions in the IV group compared with the IV group.
Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
Use in children 18 years and overUses in adults
Ciprofloxacin-susceptible organisms in urinary tract infections, prostatitis, lower respiratory tract infection, lower urinary tract infection, otitis media, sinusitis, skin and soft tissue infections, kidney, bladder, abdomenCiprofloxacin-susceptible organisms in the skin and joints infections, prostatitis, lower respiratory tract infection, upper respiratory tract infection, otitis media, sinusitis, skin and soft tissue infections, kidney, bladder, abdomen- monitor hepatic, renal, and cardiac enzymes, monitor for potential QT interval prolongation. - potent ciprofloxacin should be used with caution in children. - potent ciprofloxacin should be used with caution in patients with a history of QT interval prolongation or rare hereditary problems in the K splice sites. Caution in elderly patients. - The efficacy and safety of ciprofloxacin have not been established in patients with pre-existing aortic aneurysm or dissection and its use with caution w/ these risk factors can pose significant risks. Therefore, caution is advised in elderly patients with pre-existing aortic aneurysm or dissection and its risk factors and in these patients. Pregnant or breastfeeding women. - Avoid use by patients who are susceptible to QT interval prolongation. - Patients with a history of QT interval prolongation or risk factors for QT interval prolongation may require careful monitoring w/ monitoring for cardiac and hepatic conditions. - Ciprofloxacin should be used with caution in patients with pre-existing heart failure, peripheral atherosclerosis,earances of hypertension, MI and bradycardia. - The efficacy and safety of ciprofloxacin have not been established in patients with pre-existing heart failure, peripheral atherosclerosis,earances of hypertension, MI and bradycardia.
Ciprofloxacin (floxacin) is used to treat bacterial infections, such as:
Ciprofloxacin is also used to treat some sexually transmitted infections like gonorrhoea, syphilis, chlamydia, syphilis infection.
Ciprofloxacin is a fluoroquinolone antibiotic which belongs to the class of drugs called quinolone antibiotics. This antibiotic is used to treat bacterial infections and parasitic infections. It works by stopping the growth of bacteria.
Ciprofloxacin (Ciprofloxacin Tablets) is an oral antibiotic. It should only be used under medical supervision as it can have a serious effect on the central nervous system.
Ciprofloxacin is a medicine used to treat infections in children between the ages of 5 and 11 years. It is also used to treat severe or chronic skin infections in children and adolescents aged 4 years and above.
The dosage of Ciprofloxacin in children is based on the type and severity of the infection, and the length of treatment.
The dosage of Ciprofloxacin in children is as follows:
The maximum daily dose of Ciprofloxacin is 100 mg. For the treatment of uncomplicated genital tract infections in children, the dosage is 100 mg once daily.
For the treatment of severe or chronic skin infections in adults, the dosage is 100 mg twice daily for three days.
The duration of treatment for each infection will depend on the type and severity of the infection, the child's weight, and the severity of the infection.
The duration of treatment for sexually transmitted infections (STIs) is based on the type and severity of the infection. The duration of treatment for any infection will depend on the type and severity of the infection. The treatment for any STIs is based on the type and severity of the infection.
Ciprofloxacin tablets may be taken with or without food. However, taking it with a high-fat meal may reduce the absorption of the drug and delay its onset of action.
Ciprofloxacin is a medicine used to treat bacterial infections in children between the ages of 5 and 11 years.
The dosage of Ciprofloxacin in children is based on the type and severity of the infection, the child's weight, and the child's age.
For the treatment of serious or chronic infections, the dosage is 100 mg twice daily for three days.
The dosage of Ciprofloxacin (Ciprofloxacin Tablets) may be taken with or without food.
Ophthalmic ciprofloxacin comes as a solution (liquid) to apply to the eyes. Ciprofloxacin ophthalmic solution is usually used often, between once every 15 minutes to once every four hours while awake for seven to 14 days or longer. Ciprofloxacin ophthalmic ointment is usually applied three times a day for two days and then twice a day for five days. Use ciprofloxacin ophthalmic at around the same time every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Use ciprofloxacin ophthalmic exactly as directed. Do not use it more often than prescribed by your doctor.
You should expect your symptoms to improve during your treatment. Call your doctor if your symptoms do not go away or get worse, or if you develop other problems with your eyes during your treatment.
Use ophthalmic ciprofloxacin until you finish the prescription, even if you feel better. If you stop using ophthalmic ciprofloxacin too soon, your infection may not be completely cured and the bacteria may become resistant to antibiotics.
To instill the eye drops, follow these steps:
Wash your hands thoroughly with soap and water.
Check the dropper tip to make sure that it is not chipped or cracked.
Avoid touching the dropper tip against your eye or anything else; eyedrops and droppers must be kept clean.
While tilting your head back, pull down the lower lid of your eye with your index finger to form a pocket.
Hold the dropper (tip down) with the other hand, as close to the eye as possible without touching it.
Brace the remaining fingers of that hand against your face.
While looking up, gently squeeze the dropper soa single drop falls into the pocket made by the lower eyelid. Remove your index finger from the lower eyelid.
Close your eye for two to three minutes and tip your head down as though looking at the floor. Try not to blink or squeeze your eyelids.
Place a finger on the tear duct and apply gentle pressure.
Wipe any excess liquid from your face with a tissue.
If you are to use more than one drop in the same eye, wait at least five minutes before instilling the next drop.
Replace and tighten the cap on the dropper bottle. Do not wipe or rinse the dropper tip.
Wash your hands to remove any medication.
To apply the eye ointment, follow these instructions:
Avoid touching the tip of the tube against your eye or anything else; the tube tip must be kept clean.
Holding the tube between your thumb and forefinger, place it as near to your eyelid as possible without touching it.
Tilt your head backward slightly.
With your index finger, pull the lower eyelid down to form a pocket.
Squeeze a 1/2-inch (1.25cm) ribbon of ointment into the pocket made by the lower eyelid.
Blink your eye slowly; then gently close your eye for one to two minutes.
With a tissue, wipe any excess ointment from the eyelids and lashes. With another clean tissue, wipe the tip of the tube clean.
Replace and tighten the cap right away.
Ciprofloxacin (as Cipro) is a fluoroquinolone antibiotic. Ask your doctor if you do not know whether, or how many drops of Cipro you need to instill for the same vision loss.
The FDA has approved Ciprofloxacin and Bactrim for the treatment of urinary tract infections (UTI), such as cystitis and pyelonephritis, and urinary tract infections (UTI) caused by other bacteria.
Antibiotics are drugs used to treat bacterial infections, but they work by stopping the growth of bacteria. They include ciprofloxacin (Cipro) and trimethoprim (Bactrim).
Antibiotics are used to treat bacterial infections, but they work by stopping the growth of bacteria.
UTIs are a group of medical conditions that are caused by bacteria or pathogens that are difficult to treat with antibiotics. Some common types of UTIs include:
Side effects of ciprofloxacin and bactrim include nausea, vomiting, diarrhea, and abdominal pain.
Stade de France Pharmacy